Zomedica Corp

Good afternoon, ladies and gentlemen, and welcome to the Zometica Q2 2024 Financial Results Conference Call. At this time, all lines are in listen only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Wednesday, August 14, 2024. I would now like to bring the conference over to Mr. Mike Valli from ICR. Please go ahead.

Thank you, Operator, and good afternoon, ladies and gentlemen. Welcome to Zamedica's second quarter 2024 earnings and business update call. Joining me on today's call are Zamedica's Chief Executive Officer, Larry Heaton, and Chief Financial Officer, Peter Donato. Before we begin, we'd like to remind everyone that on this call, we will be making various remarks about future expectations, plans, and prospects that constitute forward-looking statements. These forward-looking statements are based on assumptions and there are risks that the results may differ materially from those statements. As such, Samedica cannot guarantee that any forward-looking statements will materialize and your caution not to place undue reliance on them. We refer current and potential investors to the forward-looking information and risk factors section of our public filings available on CDAR at www.cdarplus.ca and on EDGAR at sec.gov. Forward-looking statements made on this conference call represents Zomedica's expectations as of today, August 14th. I will now pass the call over to Zomedica's Chief Executive Officer, Larry Heaton. Larry?

Thanks, Mike.